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INTRODUCTION 
 Acute myocardial infarction one of the common cause  deadth 
and diseases  disability through out the world. Despite considerable 
advances  in the management of  infarction there is a considerable  
space   for  the  improvement  of  the  outcome  of  the  patients   mainly  
patients of elderly, women, patients with low education and low 
socioeconomic status. 
 The main treatment protocol in the past for  infarction was 
thrombolysis with fibrin non specific agents , subsequently with more 
fibrin specific agents  the patency rate of the infarct artery was better 
;compared to the fibrin nonspecific agent . The patency rate  and the 
TIMI flow  after thrombolysis  was based the on the agent used, whether 
it was a fibrin specific or non specific agent. Several factors predicted 
the response to thrombolytic . Throughout the world  30-70% of patients 
with  myocardial infarction , still receive thrombolysis  as the initial 
strategy. Failure of thrombolysis in Indian scenario was seen in  30-40% 
of patients.(3) 
 The present treatment guidelines for  myocardial infarction was 
primary percutaneous intervention.  Primary percutaneous intervention 
is preferred  especially if done by an operator  who has   done > 75 pci 
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procedures / year  and team  with atleast 200 pci / year  including at 
least 36 primary pci procedure / yr. The patency rate and grade of TIMI 
flow was better with primary percutaneous intervention, when compared 
to that of the thrombolytic used. Patent artery has a better prognosis than 
patients with occluded vessel.( 5-8) 
 Though primary percutaneous intervention is the first line of 
treatment in patients with acute myocardial infarction , it is not routinely 
practiced due to  various factors like delay in presentation of the 
patients, nonavailability of the cath lab, the cost factor involved in it . so 
still thrombolysis remains the most common practiced treatment in 
patients with acute myocardial infarction. Even with the recently 
available thrombolytic  treatment drugs the patency of the thecoronary 
artery was 60% (9). about  one third of patients develop spontaneous 
recanalization of  the occluded infart related artery beginning at 12-24 
hrs . decrease in mortaliy is more, by the shorter time taken to reperfuse 
the myocardium. Time delay is more important in thrombolysis than in 
percutaneous intervention, because the fibronolytic is less effective as 
the coronary thrombi mature. Similarly  every 30 minute delay in the 
symptom onset to percutaneous intervention  increases the relative risk 
of 1 yrmotality by 8%. Fibrinolysis  has been shown to improve  both 
short term and long term survival.(10,11) 
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 This study was aimedat  analysis of various demographic factors 
associated with failed thrombolysis. The coronary angiographic profile 
of patients with failed thrombolysis that is the lesion characteristics , in 
the coronary artery. The prevalence of no reflow phenomenon in 
patients  with  thrombolysis.  Is  there  is  any  variation  in  the  response  to  
the thrombolysis to different coronary artery lesion. 
 The ultimate goal of reperfusion in acute myocardial infarction is 
tissue perfusion, whether is due to primary coronary intervention or due 
to fibrinolytictherapy. This study also assess the critical lesion 
characterictic  and stenosis in coronary artery in patients with acute 
myocardial infarction . In india, thromboysis remains the main mode of 
treatment as compared to ptca. The prognosis of patients with poor 
response to failed thrombolysis or percutaneous coronary intervention is 
poor. 
 
 
 
 
 
AIM OF THE STUDY  
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AIMS AND OBJECTIVES 
x To assess the demographic profile of patients  with successful and 
failed thrombolysis . 
x To access the  angiographic lesion characteristic in patients with 
failed thrombolysis , in comparision with patients with successful 
thrombolysis. 
x To assess any predilection of an infarct artery for successful or 
failed thrombolysis. 
x To access the prevalence of no reflow phenomenon in patients 
with successful thrombolysis. 
  
REVIEW OF 
LITERATURE 
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REVIEW OF LITERATURE 
 Acute myocardial infarction is  occurrence of myocardial necrosis 
in the clinical setting of myocardial ischemia . acute myocardial 
infarction can be diagnosed by ecg, enzyme elevation and clinical 
symptom of typical angina. Myocardial infarction is a important cause 
of morbidity and mortality world wide .early recognition of the 
symptoms and prompt need for immediate treatment is mandatory to 
preserve the cardiac muscle. Myocardial infarction can be a first 
manifestation of a cardiac diseases. It may reappear in a patient with 
established cardiac diseases. Though it was mostly thought to be a 
diseases common in industrialised nation . It is a serious health issue in 
the developed nation and third world countries.(1).its has also now a 
problem in developing nation like India.(1) Myocardial infarction has an 
impact on the economic part and the pshological role in a patient  since 
it affects mainly people in there active days of life. Success rate of the 
thrombolysis is different  with the studies . success of the thrombolysis 
depends on the  type of the lesion , the thrombolytic used the time for 
the presentation of the patient in the emergency. what is the need to 
assess the need for failure to lysis. It  has been suggested that these 
patients who had failed lysis have more deadth and diseases rate. It also 
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has the role in deciding the treatment  option feasible for these patients. 
The rate of successful  thrombolysis of the coronary artery  is around 
30-70%  in  various trials. 
ELECTROCARDIOGRAPHY 
 Acute myocardial infarction is a syndrome  with features of 
decreased myocardial perfusion  symptoms like angina or  
breathlessness with electrocardiographic evidence of ST segment 
elevation.(12) 
 Acute myocardial infarction is diagnosed based on the ecg 
criteria, new ST segment elevation at the J point in two contagious leads 
with  cutoff points of 1mm ST elevation in  leads other than  v2-v3 
where the  cutoff point is 2mm in  age >40 yrs, and 2.5mm in age <40 
yrs or >1.5mm in women.Contiguous leads’ refers to lead groups such 
as anterior leads (V1–V6), inferior leads (II, III, aVF) or lateral/apical 
leads (I, aVL). Supplemental leads such as V3R and V4R reflect the free 
wall of the right ventricle and V7–V9 the infero-basal wall.(12) 
 Thrombolysis is the most commonly practiced modality of 
treatment for reperfusion in ourindian scenario. Failure  to thrombolysis 
can be diagnosed more commonly based on ecg criteria. Failure to 
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thrombolysis can also be diagnosed based on clinical symptom and 
enzyme markers.  
REPERFUSION 
 Reperfusion  it implies the tissue level of perfusion , which is best 
diagnosed by imaging techniques and by 12 lead ecg. coronary 
angiogram has a lesser  role in the assessment of reperfusion of 
myocardial tissue. Patency of coronary artery, suggest there is some 
flow in the coronaries, whatever may be the amount 
RECANALIZATION 
 Recanalization is not commented until the previous coronary 
angiogram is available which was blocked and re coronrary angiogram 
shows patent coronary artery. Patent artery doesn’t suggest that the 
tissue level of perfusion is normal. 
 Failure   to successful lysis  has increased  the probability of 
deadth and worsening of LV function (13). Ultimate role of 
thrombolysis is to achieve a TIMI  3 flow in the coronary artery. Best 
successful lysis is achieved with TIMI 3 flow. Mortality of failed lysis 
by ecgcriteria  is about 10- 20%(14). 
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THROMBOLYSIS 
 Thrombolytics have shown to dissolve the thrombus load seen in 
patients with acute myocardial infarction.  Decrease in the thrombus 
with dissolution of it have shown improve e the myocardial function.  
The improvement in the myocardial function may me be due to the 
lesser infarct size in patients who had undergone thrombolysis. Infarct 
size have shown to correlate well with the mortality in patients with 
acute myocardial infarction(22,23). Hypothesis of a open artery is the 
corner stone for the reperfusion therapy. As reperfusion therapy either 
by thrombolysis or percutaneous coronary intervention had shown to 
preserve the myocardium. the GISSI (GruppoItaliano per lo Studio 
dellaSopravvivenzanell’InfartoMiocardico) and ISIS-2 (Second 
International Study of Infarct Survival) trials in thrombolytic era have 
shown to decrease the mortality due to myocardial infarction by 30 
percentage.(10) 
 Summary of Initial Randomized Clinical Trials for Thrombolytic 
Therapy in ST Elevation Myocardial Infarction Modified from Kiernan 
TJ, Gersh BJ: Thrombolysis in acute myocardial infarction:  
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 Presently the gold standard and approved intial treatment of acute 
myocardial infarction is primary percutaneous intervention  . however 
AHA recommends thrombolytic therapy in  situation like , when the 
symptom is present for  less than 3 hrs, when catheterisation laboratory 
is occupied, there is a possibility of prolonging the treatment of 
percutaneous intervention, there is no evidence of cardiogenic shock 
with any contraindication for thrombolysis. Though thrombolytic seems 
to be an option under certain circumstances. There are certain 
disadvantages with the thrombolytic therapy, ie the increase bleeding 
rates, partial resotoration of the lumen of the coronary artery, restenosis 
rate of the infarct related coronary artery are higher as  in the primary 
percutaneous intervention group. 
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 However, because of concerns about bleeding complications, 
incomplete patency, and early reocclusion rates with thrombolytic 
therapy, combined with the fact that more primary PCIs are safely and 
successfully being performed at smaller hospitals without on-site 
cardiac surgery back-up, thrombolytic therapy has been surpassed by 
primary PCI as the treatment modality for STEMI associated with better 
clinical outcomes. 
SUCCESSFUL THROMBOLSYSIS 
 Criteria and protocol for suggesting a patient thrombolysis is 
successful is variable between the studies. Most studies which stated 
successful thrombolysis took ST segment resolution in the lead with 
maximum ST segment elevation on presentation , with greater than 50% 
resolution of ST segment after 60minutes of thrombolytic therapy. The 
resolution  of  ST  segment  is  often  associated  with  resolution  of  the  
angina. AHA guidelines suggested that the resolution of ST segment by 
greater than 70% compared to the ecg in the  lead with maximum ST 
elevation as the criteria for successful reperfusion. studies has  shown 
that decrease in the ST segment, cessation of chest pain, and occurrence 
of reperfusion arrhythmia are all suggestive of successful 
thrombolysis.(14) 
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Diagnosis of failed thrombolysis 
- Persistant chest pain 
- -ecg  ST segment resolution less than 50% of the baseline 
- -troponin t, CK_MB mass or myoglobin ratio post /pre 
thrombolysis,  
<5 at 60 minutes 
<10  at 90 minutes 
-myocardial contrast echocardiography. 
 Diagnosis of failed lysisis based on the ecgcriteria  ismaximum 
ST  segment  elevation  before  and  after  thrombolysis  at  80ms  from   
j  point.  Preferred  criteria  for  failed  thrombolysis  is  failure  of  the  ST  
segment to decrease > 50%  from the prethormbolytic stage, prerfeably 
at 60 min than at 90 minutes(11).  failure to achieve TIMI 3 flow  by 
Ecg criteria  for failed thrombolysis has a diagnostic accuracy of  
80-85%   (15) 
 In  a  meta  analysis  of  several  trials   the  mortality  with   TIMI  3  
flow was   at  4-6  wk  was  3.7% ,  7%  for  TIMI  2  and  8.8% for  TIMI   
0-1(17). Studies have shown that patient with failed thrombolysis have 
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worse prognosis (31,32,33).Assessment of the thrombolysis is clinically 
unsatisfactory, so other modalities to reassess the thrombolysis status 
has been assessed in various studies(18,19). 
CHEST PAIN 
 Characteristic chest pain of myocardial infarction has been 
termed as angina, which is usually substernally present. Angina has 
characteristic radiation to the arm, neck and left shoulder. The pain 
gradually increase in intensity.  Pain of myocardial infarction is similar 
to angina but usually persist for more than 20 minutes .patients with risk 
factor like diabetes or elderly usually don’t have the charactersistic 
angina pain. The can present with varies features , not seen with that of 
a typical angina. chest pain has to be differentiated from other cause of  
chest pain of acute onset. 
 Diagnosis of failed thrombolysis is not only depenedant on ecg 
criteria,  but  also   ton  symptomatology  like  resolution  of  chest  
pain.symptomatic improvement in the chest pain  and return to the 
baseline of the ST segment and reperfusion arrthymias are seen only in 
15% of the patients  with acute myocardial infarction. Chest pain can 
persist in patient due to decrease in the tissue perfusion. Factors like 
pericarditis in acute myocardial infarction, diabetes mellitus, pain 
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threshold, analgesics all can interfere with the analysis of chest pain.  
Complete resolution of the chest pain was seen in  only 29 percentage of 
patient with patent arteries. (19)There is always a need to diagnose 
failed thrombolysis, which has been emphasized since these patients 
needs an alternative modality of treatment. The diagnostic criteria for 
has to be simple since time is muscle. 
 The  resolution  of  chest  pain  may  be  due   the  evolving  phase  of  
myocardial infarction or due to reperfusion of the coronary artery after 
thrombolysis. The differentiation between them become difficult .early 
rise resolution of the symptomatology is more common with 
reperfusion. Patient tend to have more persistant pain if these patients 
are in the evolved phase of myocardial infarction. Similarly with 
reperfusion,  have earlier attainement of baseline segment, than patient 
who are in the evolved phase of the myocardial infarction. 
 Von essen eta1 in his studied stated that, more rapid resolution of 
ST segment in patients with  reperfusion, than in evolved myocardial 
infarction (18). 
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ELECTROCARDIOGRAPHY 
  The criteria for successful lysis has been evaluated in various 
studies .some people measured the ratio of maximum ST segment 
elevation pre and post thrombolysis. Some studies have evaluated 
acriteria  of  the  sum  of  ST  elevation  and  ST  depression.  The  most  
accepted criteria is the failure of the ST segment in the  lead with 
maximum ST elevation  to >50% from baseline value. The most 
preffered criteria was, this measurement was taken at 60 min after the  
onset of the thrombolysis. Continuously monitoring of the ST part of the 
electrocardiogram had also  been assessed in studies.though ST segment 
monitoring suggest perfusion of the myocardim is not clearly stated. 
BIOMARKERS 
 Release of biomarkers to diagnosis of acute myocardial infarction 
is not consistent . the limitation of it is that the serial measurement of 
biomarker are needed as the release pattern of biomarkers changes with 
the  thrombolytic  used  and  the  time  to  the  onset  of  infarction.,  there  is  
delay in the availability of the blood reports. The first marker to suggest 
reperfusion  is  the  rise  in  the   peak  levels  of  myoglobin.rate  of  rise  of  
troponins 3 hr after thrombolysis has sensitivity of 94 percentage  and 
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specificity  of   100  percentage   to  suggest  reperfusion.  Some  studies  
suggest that troponin may be useful to access reperfusion.(7) 
 Rapidity of increase in troponin T  3hr after lysis  can be used to 
access successful reperfusion. There are no  markers to suggest failure 
to achieve TIMI 3  flow  at 60- 90 min ( 25,26).Increase in the enzyme 
may suggest recanalization of the infarct artery , but not reperfusion  to 
suggest improvement in the microvascular dysfunction(27).Markers of  
reperfusion is less effective to diagnosis failed reperfusion  in patients  
without ST resolution(28). Fibrinogen levels  may be useful to assess 
whether the reperfusion is due to non fibriongenolysis  than due to no 
reflow(27). 
Arrhythmia  
- Arrhythmic complication are more common in patients with 
failed thrombolysis (29). Most common arrhthymia in the post 
thrombolytic period is likely  to be due to ventricular tachycardia. These 
patients can also develop other arrthymia like atrial fibrillation, 
ventricular fibrillation, supraventricular tachycardia. Reperfusion 
arrhythmia-arrhythmia to diagnosis of reperfusion is not very 
sensitive(17) 
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FACTOR PREDIPOSING TO FAILED THROMBOLYSIS 
 Failure of reperfusion many be due to many factors may be due to 
diffuse degree of critical narrowing of the target vessel, or may be due 
to microvascular no reflow. Absence of resolution of chest pain and ST 
segment not a very sensitive sign of failed reperfusion.(18).  Multiple 
factors predisposing to failed thrombolysis have been  hypotheises,  
A) Haematological factors like 
- Blood levels of fibrinogen 
-  Lipoproteins present in blood 
- Complex of antithrombin and thrombin 
B) Lesional factors like 
- Pressure in the arteries  before the level of thrombus 
- Tension or stress on the myocardium 
- Intensity of the thrombus 
- Amount of blockage in the vessel after thrombolysis 
- Type of  lesioncharactersistics of the plaque. 
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TIMI FLOW 
 Degree of ST returning to baseline  correlates with the TIMI flow 
grade in the vessel and the long term outcome (21,23).The  best 
parameter for assessing the reperfusion failure with low rate of false 
positive  in the non occluded vessel is electrocardiography(22,23,) 
.Though the patient may have achieved successful TIMI  3flow,the 
myocardial perfusion may not be normal. Patency rate in the  artery with 
TIMI  3 flow after  thrombolysis  is  54  percentage.  The best  method to 
predict the success of thrombolysis  is to access myocardial perfusion. 
Myocardial perfusion can be assessed by PET and contrast 
echocardiography. Pitfalls associated with these modalities of diagnosis 
is itscostiliear and needs expertise. TIMI flow doesn’t truthfully 
measure the tissue perfusion. 
 Features of slow flow or prolonged TFC and impaired myocardial 
blush many correlate with epicardial flow than the vessel in the 
microcirculation. the myocardial perfusion is better assessed by the 
degree of ST segment resolution.   However TIMI flow have not seen to 
show to correlate with the myocardial   perfusion. Some studies  
suggested that the TIMI  3 flow is more common among smokers than 
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non smokers  and seen in first time myocardial infarction (1) but TIMI  
3 flow  patient had  similar risk factor like diabetes, hypertensison. 
TIMI GRADING 
 For  comparison  of  the  flow  in  the  coronary  artery  system,  the  
grading of  the TIMI flow is done , grade 0  complete occlusion  grade 2  
minimal entry of the contrast material, beyond stenosis without 
perfusion of distal coronary bed. Grade 3 normal flow. Recanalized  
coronary artery is stated only if previous coronary angiogram is 
available. If earlier angiogram is not present it will only say about the 
patency  of  the  coronary  artery   during  the  angiogram.  Studies  to  asses  
the TIMI flow where angiogram was done 90 min or better with 60 min 
after  start of thrombolytic(24). 
TIMI FRAME COUNT   
 Quantitative assessment of the briskness of the coronary blood 
flow(1). There is  a difference in frame count for different coronary 
artery , which takes in toconsideration of the vessel size and length of 
the vessel(10). Frame count is the no of frames needed for the contrast 
material to reach the distal coronary bed. TIMI frame count can 
influence the mortality rate in acute myocardial infarction. With TIMI  
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frame count as the base line  various factor have been shown to delay 
the coronary blood flow after thrombolysis, like thecoronary stenosis, 
size of the lumen diameter, the length of the artery distal to the stenosis, 
pulsatile flow and thrombus in lesion. Studies have shown that patient 
with inferior wall myocardial infarction have better ST segment 
resolution. Left anterior descending artery have lower rates of 
myocardial reperfusion. 
RESCUE PTCA 
 Time to diagnosis of  acute myocardial infarction is critical, the 
myocardial damage increase with the delay in the reperfusion. 
Thrombolysis trial have shown that the maximum benefit of 
thrombolysis is seen in patients who presented early to the hospital with 
time  duration  lesser  than  3  hrs  of  onset  of  chest  pain.  The  benefits  of  
rescue percutaneous intervention has been questioned  if the time of  
presentation of the patient is more than 12 hrs of chest pain 
 Limitations of rescue angioplasty – repefursion of the coronary 
artery  achieved  more  as  the  time  progress  form  the  institution  of  
thrombolytic so early treatment with rescue PTCA may not be 
warranted. Rescue angioplasty patients have increase use of contrast, 
reperfusion injury, emboli, increase in the rate of bleeding complication. 
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NO REFLOW PHENOMENON 
- Myocardial no reflow phenomenon can occur after thrombolysis  
due to microvascular damage and reperfusion injury.No reflow 
phenomenon is more come after rescue PTCA  than after primary 
PTCA(34,35). 
- Angiographically myocardial perfusion can  be graded as 
- Grade 1  no perfusion of myocardium, stain on the myocardium 
present 
- Contrast enters the micro vasculatue, but still persistant and the 
end of wash out  phase  
- Contrast is minimally persistant at the end of wash out phase. 
 In a study conducted  bysudbhindrarao , patilbs  stated that  about 
25-50 percentage of patient failed to achieve reperfusion. Of the 50 
patients 60 percentage achieved successful  repefusion.  Persistant of 
chest pain  and persitant ST segment elevation was associated with 
failed reperfusion.  No reflow phenomenon is noted in primary PTCA 
and rescue PTCA. Though no reflow phenomenon noted commonly 
after  intervention. It is also  seen in pateients who are thrombolysed 
with fibrin specific or nonspecific agents. whether its is common in 
primary PTCA patients or after rescue PTCA. It is mostly noted in 
patients with rescue PTCA. 
MATERIALS AND 
METHODS 
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MATERIALS AND METHODS 
 This study was conducted in Rajiv Gandhi Government general 
hospital   in the Department of cardiology during the year 2013-2014. 
The involved a total of 59 patients .these patients where grouped in 
those with successful thrombolysis and those with failed thrombolysis. 
Patients who presented to the rajiv Gandhi government general hospital, 
who where diagnosed to have acute myocardial infarction between  
November 2013 and march 2014 where included in the study. 
 About 59 patients with acute myocardial infarction who presented 
to the cardiology coronay care unit, who were thrombolysed where 
included in the study Sample size total case of 59 patients. 
STUDY GROUP SELECTION 
 Institutional ethics committee clearance was obtained to conduct 
this study in our hospital .all patients provides written informed consent 
in the language known to participiate in the study. 
INCLUSION CRITERIA 
 Patients who were admitted in rajiv Gandhi government general 
hospital coronary care unit, who had meet the criteria for acute 
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myocardial infarction where included in the study. Patients who had 
electrocardiographic evidence of acute myocardial infarction. Patients 
classified in to successful thrombolysis if there was a more 50% ST 
segment resolution in the lead with maximum ST elevation from  at the 
time of presentation to 60 minutes after thrombolysis compared to 
electrocardiogram taken, with resolution of the chest pain. Failure of 
thrombolysis patients where grouped as those patients who ST segment 
failed  to show greater than  50% resolution of ST segment in the lead 
with the maximum ST elevation at the time of presentation with that 
compared to the electrocardiogram taken 60 minutes after the onset of 
the thrombolysis. Patient where also included in the failed thrombolysis 
if the patient continued to have persitant chest pain. 
EXCLUSION CRITERIA 
- Patient with  contraindication for thrombolysis 
- Patient with evolved myocardial infarction 
- Patient with history of old myocardial infarction 
- Patient with associated left bundle branch block with myocardial 
infarction. 
- Patient who are dying with  60 minutes of streptokinase theraphy. 
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- Patients with acute myocardial infarction with chronic kidney 
diseases who cant undergo coronary angiogram 
STUDY PROTOCOL 
 Patient  who  presented  to  coronary  care  unit  with   acute  
myocardial infarction and diagnosed based on the electrocardiographic 
criteria. Patient where selected after looking for the inclusion and 
exclusion criteria. These patients where thrombolysed with 15  lakhs 
units of streptokinase  after ruling out any contraindications. 
CLINICAL ASSESSMENT 
 All patients where enquired about the history , especially with 
regard  to the onset  of  chest  pain and time delay to the presentation to 
the hospital . other history regarding the risk factor for coronary artery 
diseases like diabetes mellitus and the duration of the diseases  and 
whether the patient is on insulin or oral hypoglycemic agents and, 
history regarding hypertension  and duration of treatment were taken, 
previous history of myocardial infarction, smoking history for the 
duration  of  smoking  and  no  of  cigarettes  per  day,  whether  they  are  
current smokers or not and alcoholic history where enquired.  Any 
family history of coronary artery disease or sudden cardiac deadth in the 
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family was enquired. Hemodynamic parameters where assessed. All 
patients where on continuous monitoring during the period of lysis and 
until the patient is in coronary care unit. 
ELECTROCARDIOGRAPHIC FINDINGS 
 All patients had a 12 lead electrocardiography on presentation to 
the coronary care unit. Patient also had a repeat 12 lead 
electrocardiography, after 60 minutes of intiation of thrombolysis.  
Based on the electrocardiography patient where classified as those 
having anterior wall myocardial infarction if had ST segment elevation 
in anterior chest leads, and inferior wall infarction, if they had ST 
segment elevation in the inferior leads ii, iii, avF. All 
electrocardiography where looked for any rhythm disturbance like 
accelerated idioventricularrhytm, atrioventricular block etc. all patients  
after clinical, electrocardiographically and echocardiographically 
confirmation of  acute myocardial infarction  where given thrombolytic 
therapy. Before initation of thrombolytic theraphy patient was 
questioned for any contraindication for thrombolytic therapy. Patient 
received thrombolytic therapy if there whereno  contraindication for 
receiving streptokinase. All patients  under went blood investigation like 
complete blood picture, blood sugar, renal function parameter, total 
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cholesterol and triglycerides. Patients who where decided for 
thrombolysis, where treated with 15 lakh units of streptokinase  infusion 
over 1 hr, with close monitoring. Post streptokinase after 60min of 
thrombolysis a repeat 12 lead electrocardiography was taken. Patient 
was classified as have successful thrombolysis if the lead which had 
maximum ST segment elevation on presentation , showed a greater than 
50% decrease in the ST segment. The ST segment was measured  at 80 
msec  form    the  J  point.  patient  was  also  questioned  for  the  time  of  
resolution of the chest pain patient where stated to have failed the 
thrombolysis if the electro cardiogram after 60 min of streptokinase 
failed to show resolution of the ST segment more than  50% compared 
to the electrocardiogram taken at presentation.patient with failed 
reperfusion also had persistant chest pain, more than 2 hrs after 
thrombolysis patient who had inferior wall myocardial infarction also 
had a  electrocardiogaram done with right side chest lead and posterior 
lead. 
ECHOCARDIOGRAPHIC ASSESSMENT 
 All patients admitted in the coronary care underwent 
echocardiographic with EASOATE machine before thrombolysis. 
Echocardiographic assessment for LV function was assessed by 
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modified simpsons method patient was classified as normal LV function 
if the ejection fraction was above 55 percentage, mild LV dysfuntion if 
the ejection fraction was between 46-55 percentage, moderate LV 
dysfunction if the ejection fraction is between 30-45 percentage, severe 
LV dysfunction if the  ejection fraction was below 30%. all patient   
where looked for the regional wall motion abnormalities with wall 
motion score index . wall motion abnormality was described as 
hypokinesia , akinesia , dyskinesia and aneurysmal. Wall motion score 
is given as  
 1= NORMAL 
2= MILD HYPOKINESIA 
3= SEVERE HYPOKINESIA 
4= AKINESIA 
5= DYSKINESIA 
 The  wall  score  was  totalled  and  was  divided  by  the  number  of  
segments. More  the wall motion score   the greater is the LV 
dysfunction. 
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 Mechanical complication of acute myocardial  infarction where 
looked in  like ventricular septal rupture, mitral regurgitation, free wall 
rupture with 2D echocardiography and mechanical complication. Patient 
with global hypokinesia , or with hypokinesia of the non infarct artery 
segments where not included in the study. Patient whose regional wall 
motion abnormalities correlates with the electrocardiographic criteria 
for involvement of the myocardial segments where included in the 
study. 
CORONARY ANGIOGRAM 
 All patients , in the study both in the successful thrombolysis and 
failed thrombolysis group underwent coronary angiogram. The 
angiogram was done within  72 to 96 hrs of hospital admission.  The 
coronary angioram was done by the consultant cardiologist in our 
department  in our cath lab with TOSHIBA  infinix machine. All 
patients where taken for coronary angiogram after taking informed 
consent from the patient. Pre procedure skin preparation ,inj tetanus 
toxoid and  xylocaine test dose was given to all patients .diabetic patient 
who where on oral hypoglycemic agents where changed over to regular 
insulin  as  per  the  diabetologist  advice.  patients  who   where  
hemodynamically unstable where  in cardiogenic shock or 
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hemodynamic instability where not taken up for coronary angiogram. 
Patient with previous contrast allergy , severe anemia, acute renal failure 
, acute stroke where not taken up for coronary angiogram. Coronary 
angiogram  was  done  by  radial  or  femoral  route.  Majority  of  patient  
underwent coronary angiogram  through the femoral route. Patient who 
had moderate to severe LV dysfunction with positive allenstest, 
coronary angiogram was done by radial route. In majority of  patients 
via  the  femoral  route  standard   6F  judkins   3.5   or  4  judkins   left  and  
right catheter was used to engage the left  coronary and right coronary 
artery respectively. If the coronary angiogram was done  through the  
radial route 5F tiger catheter was used. optimal angiographic views 
where taken to assess the lesion characteristics. coronary arteries are 
visualized after iodine contrast injection. Coronary arterial segments are 
divided in to 29 segments according to the bypass angioplasty 
revascularization investigators. Patient where stated to have significant 
coronary artery diseases if the diameter stenosis is more than 50 
percentage comparing to the normal vessel luminal diameter. 
 Left anterior descending artery supplies the major part o f the LV  
myocardium in right anterior oblique view, left anterior descending 
artery  is seen coursing on the anterior surface of the heart. While in the 
left anterior oblique view left anterior descending artery is seen to 
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transeverse the course between the right and left ventricle.  Diagonal 
artery from where it arises from the left anterior descending artery is 
better seen in left anterior oblique of  sixty degree and cranial angulation 
of 40 degree. in four fifth of patient in the general population have type 
3 left anterior descending artery.in one fifth of the patient the apex of 
the ventricular surface is supplied by the right coronary artery or the left 
circumflex artery, which gives rise to the posterior descending 
artery.The left anterior oblique  with cranial tilt may show the middle 
portion of the left anterior descending artery better. Left anterior oblique 
with  cranial  tilt,  shows  the   proximal  ,  mid  ,  distal  part  of  the  left  
anterior descending artery. This view also show the separation of the 
diagnonal branches of the left anterior descending artey and the septal 
branches of the left anterior descending artery.The  anteroposterior view 
with   the  cranial  tilt,  shows   the  middle  part  of  the  left  anterior  
descending coronary artery, and also the separation  of the diagonal  
branch of coronary artery and the septal branches of coronary artery 
from the left anterior descending artery.  Left anterior oblique with 
slight caudal tilt shows the proximal of the left anterior descending 
artery  and  also  the  proximal  portion  of  the  left  circumflex  coronary  
artery.  Antero posterior view with slight caudal tilt shows the  proximal 
left anterior descending coronary artery , which is a branch of the left 
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main coronary artery. Distal portion of the left anterior descending 
artery is better seen in the right anterior oblique view with caudal tilt. 
 Right coronary artery as compared to the origin of the left 
coronary artery is  arising from somewhat a lower level than that of the 
left coronary artery.  The main branches of the right coronary artery are 
the conus branch form the right coronary artery which is the first branch 
from the right coronary artery. The second next branch from the right 
coronary artery is the sino atrial nodal artery.  In half of the patients the 
conus artery arises as a branch from the proximal part of the right 
coronary artery. In the other half of the patients the conus artery directly 
arises from the  right coronary artery if the conus artery arises directly, 
then the Level of the origin of the direct branch of conus artery is 
slightly superior as compared to that of the level of arising of the  right 
coronary artery.the next important branch of the right coronary artery is 
the sinonodal artery. This artery can arises form the left cirumflex 
coronary artery which is seen in 40 percentage of  patients. sinus nodal 
artery is   a branch of the   right coronary artery in 60% of patients. The 
part of the right coronary artery after the origin of right ventricular 
branch gives rise to a  many acute marginal branches. The right 
coronary artery  divides in to posterior descending artery and the 
posterolateral branches. 
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 Visualization of the ostium of RCA is best done  in the left 
anterior oblique view, may or may not need a cranial or caudal tilt. 
Lateral view some time shows the  origin of right coronary artery better. 
Right coronary artery in its proximal part are best assessed by left 
anterior oblique with cranial or caudal tilt. Forshortening of the 
proximal right coronary artery might occur in the right anterior oblique 
.left anterior oblique with cranial tilt and right anterior oblique , left 
lateral views delineates the middle part of the right coronary artery. Left 
anterior oblique and ap cranial view , delineates the proximal part of the 
posterior descending artery and its bifurcation. AP view and RAO  view  
delineates the middle part of the posterior  descending artery better. 
STASTICAL ANALYSIS 
- Statistics was done with  statistical package  for social sciences 
10.0 program. 
  
RESULTS AND ANALYSIS 
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RESULTS AND DATA ANALYSIS 
 All patients in the study group was analysed statically in the 
study. The study group was divided in to two groups as those patients 
with  successful and failed thrombolysis. The total number of patients 
selected in the study was 59 patients .the selection  of the patients was  
based on inclusion and exclusion criteria. All patients in the study 
underwent thrombolysis with streptokinase of the total number  59 
patients in the study group, 31 patients belonged to successful 
thrombolysis group and 28 patients belonged to the failed thrombolysis 
group.   All  patients  in  the  study  group  were  categorised   based  on  the  
age, sex, the region of myocardial infarction, time to lysis, presence of 
diabetes mellitus, hypertension, whether patient had risk factor like 
smoking, alcoholism, hyperchlolestremia, ejection fraction by 
echocardiography. Angiographically the variables included in the study 
where, number of coronary artery involved, the percentage of stenosis in 
the artery, the lesion characterescitic of the coronary artery, whether it is 
a  type  A,  B,  C  lesion.  All   patients   in  the  study  underwent  coronary  
angiogram within a week of admission in to hospital for acute 
myocardial infarction. 
33 
 In the 59 patients included in the study 53 % of patients where in 
the successful  thrombolysis group and 47 % of patients where in 
included in the failed thrombolysis group. Patients presenting with 
myocardial infarction was more common in the age group between 40-
60  yrs  of  age.   There  was  no  significant  difference  in  the  age  wise  
variable of presentation between the failed thrombolysis and the 
successful   thrombolysis group with the p value of (0.535). which was 
not statistically significant.  
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Above 6040-60Below 40
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 Successful  
thrombolysis 
Failed 
thrombolysis 
 
Age in yrs<4o 71.4% 28.6%  
Age in yrs 40-60 64.5% 51.2% P value <0.535 
Age > 60 yrs 54.5% 45.5%  
 
  Among the total 59 patients , 58 patients where male  and only 
one female was present in the study after analysing the data, this female 
patient was in successful thrombolysis group.  Sex variable comparision 
between the  successful  thrombolysis and the failed thrombolysis was 
not statically significant with a p value of (0.338).  
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 Successful lysis Failed lysis  
Male  51.7%(30) 48.3%(28) P value <0.338 
female 100%(1) 0%(0)  
 
 With  a  total  of  59  patients,  40  patients  had  an  anterior  wall  
myocardial infarction, with the remaining 19 patients had acute inferior 
wall myocardial infarction. In the patients within the anterior wall 
myocardial infarction, about 42.5% patients had successful thrombolysis 
and, 57.5% patients had failed thrombolysis in the anterior wall 
myocardial infarction group. patients with anterior myocardial infarction 
had more thrombolysis failure than patients with inferior wall 
Sex
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myocardial infarction which was statically significant with a p value  
of  0.025. among the patients with inferior wall myocardial infarction. 
patients who had inferior wall myocardial infarction where  19 patients, 
among the patients 15 patients had successful thrombolysis, while 4 
patients had failed thrombolysis. In patient with inferior wall myocardial 
infarction , 75% of patients had successful thrombolysis, while 25 % of 
patients had failed thrombolysis, which was statically significant with a 
p  value of <0.013. comparing the significance of p value, patient with 
inferior wall myocardial infarction where more significantly associated 
with successful thrombolysis than patient who had anterior wall 
myocardial infarction.(p<.013 vs p<.025). 
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 Successful 
thrombolysis 
Failed 
thrombolysis 
 
AWMI 42.5%(17) 57.5%(23) P value <0.025 
IWMI  73.7%(14) 26.3%(5)  
 
 SUCCESSFUL FAILED  
IWMI 75%(15) 25%(5) P value <0.013 
AWMI 41.0%(16) 59%(23)  
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 The time taken for lysis of patient on arrival to coronary care unit, 
was divided in to three sub division, like patient who arrived < 3hr of 
onset of chest pain , and those between 3-12 hrs , > 12hrs.   in the total 
of 20 patients who arrived to hospital  within < 3 hrs of chest pain 85% 
of  patients  had   a  successful  thrombolysis  while  only   the  remaining   
15% of patients had a failed thrombolysis patient who presented after 3 
hrs of symptom onset where more commonly seen with failed 
thrombolysis . in the group of patients who presented >12 hrs after onset 
of  chest  pain  ;of  the  5  patients,  nearly  80%  of  patients  had  a  failed  
thrombolysis than successful thrombolysis. Those patients who 
presented  between 3-12hrs after onset of chest pain nearly 61% of the 
patient had a failed thrombolysis as compared to the patients with  39% 
of  patients  with  successful  thrombolysis.  Patient  who  had  time  to  
thrombolysis of less  than 3 hrs had a statically significant p value of 
< .001. 
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TIME TO 
THROMBOLYSIS 
SUCCESSFUL FAILED 
 
<3hrs 85%(17) 15%(3)  
3-12 hrs 38.2%(13) 61.8%(21) P value <0.001 
>12 hrs 20%(1) 80%(4)  
 
 Relief  of chestpain, after  2 hrs of thrombolysis was studied in all 
patients included in the study. Of the total patients  36 patients had relief 
of chest pain within 2hrs  after the  thrombolysis,  77.8% of patients in 
the  successful  group   had  relief  of  chest  pain  within  2  hrs  of  
thrombolysis, but only 22.2%  of patients in  the failed thrombolysis 
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group had  resolution of chest pain less than 2 hrs   after thrombolysis. 
This difference in the relief of chest pain was statistically  significant  in 
the successful   with a p value of (ooo). 
 Of all the patients included in the study  19 patients  had a history 
of  diabetes  mellitus,  of  these  patients  about  73.7%  of  patients  had   a  
failed thrombolysis as compared to the patient in the successful group of 
26.3%  of  the  study  population  in  diabetes  mellitus.   Failure  of  
thrombolysis in diabeteic population as compared to the non diabetic 
population was  statically significant with  a p value of (.005).  the 
significance  diabetes mellitus as a risk factor for  failed thrombolysis  is 
more than that of hypertension. 
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 Successful Failed  
Diabetes  26.3%(5) 73.7%(14) P value <0.005 
No diabetes 65%(26) 35%(14)  
 
 Similarly patient who had a hypertension , where analysed in both 
the groups , patient who had systemic hypertension in all patients was 
15 patients  of the 15 patients  73.3% of patients had failed thrombolysis 
and 26.7% had successful thrombolysis , with a pvalue of (<.020).  
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 Smokers were found in 40 patients out of the 59 total patients , 
55% of patients in the successful group where smoker and 45% of the 
smokers where in the failed thrombolysis group. The statistically 
significance among smokers in the successful and the failed lysis group 
was not significant with a p value of (.583) there was also significant 
difference in the nonsmokers group in patients with successful or failed 
thrombolysis. 
  
43 
 
 
 
 
 
 
 
 
 
 successful failed  
smoker 55%(22) 45%(18) P value0.583 
Non smoker 47.4%(9) 52.6%(10)  
 
 Alcoholic patients  in the total study population was about 14 
patients , with 64.3% of patients where in the successful lysis group and 
35.7% in the failed lysis group. In the successful group 29% of patient 
where alcoholics and  about  17.9%  in the failed lysis   where alcoholics 
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This difference between the two groups of patients was not statistically 
significant with a p value of (<0.314). 
 All patients in the study population had a echocardiographic 
evaluation , patient classified as having normal LV function, mild 
,moderate , severe LV dysfunction. Only  12 patients in the study 
population had normal LV function. 91%of patient in successful lysis 
group had a normal LV function, while only 8.3% of patient of the 
failed thrombolysis group had a failed thrombolysis. Moderate left 
ventricular dysfunction is more common in patient with failed 
thrombolysis , than patients with successful thrombolysis.patients with 
failed thrombolysis had left ventricular dysfunction , than patients with 
successful thrombolysis, which was statistically significant with a p 
value of <002. 
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EJECTION 
FRACTION 
SUCCESSFUL FAILED  
>55% 91.7%(11) 8.3%(1)  
45-54% 57.7%(15) 42.3%(11) P value <0.002 
35-44% 25%(5) 75%(15)  
<35% 0%(0) 100%(1)  
 
 Patients in the study population  where  divided in to single vessel 
, double vessel and triple vessel disesases depending on the number of 
coronary artery involved.  The stenosis was considered significant if the 
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diameter stenosis was greater than 50% in the study population group 20 
patients had a single vessel disease, of these 20 patients 70% of them 
had failed thrombolysis and 30% had a successful thrombolysis patient 
in the successful group only 19 % percent had a single vessel diseases, 
while patient in the failed lysis group about 50% had a single vessel 
diseases. This data was statically significant with a p value of (<.013). 
The  study   had  7  patient  with  double  vessel  diseases  of  which  85.7%  
had failed thrombolysis and 14.3% had a successful thrombolysis. In the 
patient group of successful thrombolysis only 3.2% had double vessel 
diseases, whereas the failed lysis group had 21.4% of double vessel 
diseases,  which was statistically significant.  All patient in the data with 
triple vessel disease belonged to the failed lysis group, none of the 
patients in the successful group had a triple vessel diseases. 17.9% of 
patient in the failed thrombolysis group had  triple vessel diseases. 
 The statistically data was later interpreted as patient with 
multivessel diseases, as those with single vessel diseases. Total of 20 
patients had single vessel diseases of which 30% where in the successful 
thrombolysis  group and 70% in the failed thrombolysis group. Patient 
who had multivessel diseases include about 10 patients of which 90% 
where in the failed thrombolysis group and  10% in the successful 
thrombolysis group. 
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SINGLE VESSEL 
DISEASES 
30%(6) 70%(14) P value 0<.000 
MULTIVESSEL 
DISEASES 
10%(1) 90%(9)  
 
 
 Hypercholestroemia is a risk factor for coronary artery diseases, 
mean total cholesterol in patients with  successful thromboysis was 
144.58 and that of patients with failed thrombolysis was  177.68 which 
was statically significant. 
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 TIMI flow grading in the each coronary artery was compared in 
both successful and failed thrombolysis group with variables as TIMI 3 
flow  and  those  with  TIMI  <3  flow  .   in  the  study  population    of  
assessment of TIMI  flow in the  LAD  territory, total of 27 patients had 
a TIMI  3 flow in the coronary artery with 85.2% in the successful 
thrombolysis group as compared to the failure of thrombolysis which 
had about 14.3% patients. Patient who had less than 3 TIMI flow  where  
a total   of 32 patients and it was more common in patients with failed 
thrombolysis in about 75% of patient, and in the successful 
thrombolysis group it was seen  in 25 of patient. In the successful group 
only 25.8% had TIMI flow < 3 as compared to the patient with failed 
thrombolysis who had 85.7% which was statically significant with a p  
value of >.000. Similarly the TIMI  flow in the right coronary artery was 
assessed  and  patient  who  had  a  TIMI   flow  of  3  in  the  right  coronary  
artery was  43 patients ,with  62.8% in the patients with successful lysis 
and 37.2% in the failed lysis group. Among the patient in the successful 
thrombolysis group 62.8%had TIMI 3   flow while only 37.2% in the 
failed lysis  had a TIMI  3 flow with a p value of <.010. similarly  
patient with  successful lysis had 58% TIMI  3 flow, as compared to the 
patient group of failed lysis  which had 42% TIMI  3 flow, which was 
statistically significant with a p value of <.048. TIMI 3 Flow after 
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successful thrombolysis was stastically more significant in left anterior 
descending artery than in the right coronary artery. 
Percentage stenosis    
 The study population was divided in to patients with significant 
coronary artery diseases and patients without significant coronary artery 
diseases  (>50%)  of  the  total  no   of  patients  about  26  patients   had  
normal coronary artery. The remaining 33 patients about 14 patients had 
a stenosis of < 50 percentage stenosis and 19 patients had a percentage 
stenosis of > 50% stenosis.  In the patients with less than 50% stenosis  
about 48.4% of  patients belonged to the successful thrombolysis group , 
as compared to 42.3% patients in the failed thrombolysis group. 
 In the group with > 50% stenosis  nearly 89.5% of patients had 
failed thrombolysis as compared to 10.5% had successful thrombolysis 
.which was stastically significant with a p value of 0.000 
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LESION CHARACTERISITCS  
 Of the total patient only 10 patient had type A coronary artery 
lesion, type A  lesionwhere more common in failed thrombolysis 
patients  (70%) , and in only 30% of successful thrombolysis.patients in 
the successful thrombolysis group 9.7% had type A lesion as compared 
to 25% patients in the failed thrombolysis group which was stastically  
not significant with a p value of <.117 . 
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Type A lesion successful failed  
Yes  30%(3) 70%(7) P value,0.117 
no 57.1%(28) 42.9%(21)  
 
  Patient who had type B lesion where 25 patients out of the 59 
patients , 76% of type B lesion where found in the failed lysis group and 
24% of type B  lesion where found in the successful lysis group.  In the 
successful thrombolysis patients type Bleion are seen in 19.4% and in 
67.9% in the failed thrombolysis group which was statistically 
significant. With a p value of <.000. 
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TYPE B SUCCESSFUL FAILED  
YES 24%(6) 76%(19) P value of <0.000 
NO 73.5%(25) 26.5%(9)  
 
 
 
 
 
 
 
 
 
 The  total   number  of  patients  who  had  type  C  lesion  was   6  
patients, all the patients belonged to the failed thrombolysis group. 
Which was stastically significant with a p value of <0.007 
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TYPE C SUCCESSFUL FAILED  
YES 0%(0) 100%(6) P value of <0.007 
NO 58.5%(31) 41.5%(22)  
 
 Among the total patient in the successful lysis group the 
comparison was made whether  successful thrombolysis is more 
common in LAD , RCA, LCX.  26 patients in the LAD  group patients 
only 15.4% had successful thrombolysis. In failed thrombolysis of the 
left coronary artery was more common  and seen in  78.6% of patients . 
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NO REFLOW PHENOMENON 
-  In the total study population, no reflow phenomenon was see 
only  in  the  failed   thrombolysis  group.   Out  of  the  28  patients  ,   
2  patients  had   no  reflow  phenomenon.   These  patients  had   a  
normal epicardial coronary artery, however the ST segment 
persistently elevated. In this study population, no reflow 
phenomenon was seen in 5% of the patients. Both these patients 
had anterior wall myocardial infarction both these patients had 
hypertension as a common risk factor. 
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DISCUSSION 
 In this study population of 59 patients, based on 
electrocardiography  patients where divided in to successful group and 
the failure of thrombolysis group .52.5% of patients   had successful 
thrombolysis group and only 47.5% had failure to thrombolysis.the 
percentage of patients who had  failed thrombolysis where more 
common in anterior wall myocardial infarction than in  inferior wall 
myocardial infarction which was stastically significant. Patients who 
had inferior wall myocardial infarction were more like to have 
successful thrombolysis based on electrocardiography than patients with 
failed thrombolysis. 
 The incidence of failed thrombolysis varies between different 
studies, but roughly it ranges from  25-45 percentage. 
 Katyal et al  in his analysis showed the patients who showed 
failed, thrombolysis where about 34 percentage.  (3) Our  study showed 
a incidence of 47% for failed thrombolysis. Subindraetal in his statically 
data on patients with failed lysis showed that 40% had failed 
thrombolysis. (38) 
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 The study conducted by Richardson  SGetal showed  about 44%  
incidence of failed thrombolysis.(39) The variation in the incidence 
between the studies was probably due to baseline rule involved in the 
diagnosis of failed thrombolysis, the  thrombolytic drug used. 
 Sutton  etal   analysed  the  patient  with  failed  thrombolysis  was  
present in 40 percentage of  patients  in his study. 
 Diabetes patients in this study had more number of failed 
thrombolysis, than patients with  successful thorombolysis. In our study, 
73.7 percentage of the  diabetic population had failed thrombolysis 
while only 26 percentage in the successful thrombolysis where diabetic  
which was statsically significant.  In the study  done by   sudhindrarao 
20 percentage of diabetic population  had failed thrombolysis as 
compared to the patients with successful thrombolysis only 13 
percentage had diabetes mellitus. Though this was not statically 
significant in his study.(38) 
  Samir M. Rafla, et al.,  in his studied of patients in comparison of 
diabetic vsnondiabetic, patient with  in the diabetic group was seen in 
18% of patients and patients in the non diabetic group about 62.5% 
showed significant resolution of the ST segment, which was stastically 
significant.(40) 
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  In the  GISSI -2  trial , death rate  within the hospital  in patients 
with diabetes mellitus was modest and ther e was no difference between 
the type  1 and type 2 diabetic patientsdiabetes (8.7 percentage  and 10.1 
percentage respectively, vs. 5.8 percentage in nondiabetic patients) .  
In female  deadth rate is more in females with  type 1 diabetes mellitus  
and slight modest in patients with type 2 diabetes mellitus  
(24.0 percentage and 15. percentage, respectively, vs. 13.9 percentage 
for nondiabetic patients). 
 The increase in in-hospital mortality of diabetic patients was 
moderate and similar for men with insulin- and noninsulin-dependent; in 
women, mortality was markedly higher for insulin-dependent and only 
slightly higher for noninsulin-dependent diabetic patients. 
 Hypertension another common association in heart disesases,  
subindrawdetal in his study  showed that 20 percentage of patients in the 
failed thrombolysis group  had hypertension , but only 16 percentage in 
the successful group    which was not stastically significant (38). In this 
study about eleven patients  in the failed lysis group had hypertension 
which constitutes to  about 39.3% in the failed lysis group as compared 
with the successful group which has only 12.9% of patients . 
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 Lee et al in his study showed, in his study population about  37 
percentage of patients had hypertension,  in which nearly 66  percentage 
of patients in   had failure of thrombolysis. The hypothesis for decrease 
success rate in these patients is due to the endothelial  abnormality 
associated in these patients.(36) 
 Time to  thrombolysis , also contribute to thrombolysis failure 
.Lee Y Y et al  patients who were thrombolysed after 6 hrs after onset of 
chest pain,  70%  percentage  patients had  failure to thrombolytics.  also 
stated that for each 60 sec delay in the thrombolysis time  form 
symptom onset, the failure to thrombolysis was more by 10 
percentage.(36) 
  The GISSI -2 trial showed that patient who presented to the 
hospital  less  than  6  hrs  of  onset  of  chest  pain  had  a  better  prognosis   
than patient who presented late to the emergency . subindraetal in his 
study showed time for door to needle time was more(5.85±2.47 hrs) in 
failed thrombolysis patients   while it was only (4.55±2.4 hrs).in the 
successful group. 
 In our study   85% of patients who presented to the coronary care 
unit less than 3 hrs after onset of symptoms had successful thrombolysis 
, but only 20 percentage of patients  who presented to ccu after 12hrs of 
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chest pain had a successful thrombolysis which was stastically 
significant. 
ANGIOGRAM OF A PATIENT WITH FAILED 
THROMBOLYSIS 
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ANGIOGRAM OF A PATIENT WITH SUCCESSFUL 
THROMBOLYSIS 
 
 
 
 
 
 
 
 Smoking is another important risk factor in acute myocardial 
infarction. 
 Angiographic data of  GUSTO 1 showed a higher TIMI flow in 
the patients  who were smokers as compared to that of the non 
smokers(41% vs. 33%, p 5 0.02).in the TEAM -, study population 
patients who were smokers  had a better possibility of  TIMI  3 flow, 
which not related to infarcted artery. The pausible mechanism is due to 
increased thrombus in smokers, while the non smokers have more 
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possibility of atherosclerotic diseases.  In our study  more number of 
patients where smokers in the successful thormobolysis  group as 
compared to  the failed lysis group however it was not stastically 
significant in our study. 
 Studies comparing the significance of thrombolysis have 
compared in various studies. The gusto study had decrease in the deadth 
rate in  patient with anterior myocardial infraction. 
 Lee et al, in his study showed that anterior wall myocardial 
infarction was associated with less successful thrombolysis.(36) In our 
study also patient with inferior wall myocardial infarction had better 
resolution of the ST segment than patient with anterior wall myocardial 
infarction. 
 TIMI flow of grade 3 there is important for successful 
thrombolysis sutttonetal  in his showed that patient had mortality benefit 
only if they achieved a TIMI 3 flow , there was no significant   decrease 
in the deadth rate in patients  who had TIMI 2 OR 1 flow in the 
coronary artery. 
 Gusto trial, suggested that the successful lysis of the patients is 
based on the TIMI  flow after thrombolysis.(4) 
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 Jeffrey et  al  in the TEAM -3 study ,  showed  that  these patients  
have more ejection fraction  and lesser deadth rate.(37) In our study the  
patient who had successful thrombolysis had better TIMI  flow than 
patients with failed  thrombolysis. 
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CONCLUSION 
x In  the  study  population  the  prevalance  of   successful   
thrombolysis  was  53%  and  the  prevalence  of  failed  
thrombolysis was 47%. 
x Failed thrombolysis was more common in patients who had 
diabetes and hypertension as risk factor.  Though smokers 
and alcoholic where more common in the successful group, 
it was not statistically significant  for contributing to failed 
thrombolysis 
x type B  coronary  lesion angiographically  was more 
common in failed lysis group. 
x The prevalence of no reflow phenomenon in the   failed 
thrombolysis patient in this study was 5% 
x 29% of patients with persistant STelevation where 
symptom free  after thrombolysis. 
  
LIMITATIONS 
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LIMITATIONS OF THE STUDY 
x Study population was small 
x Not a randomized study   
x ST  segments is dynamic, so faults can occur in diagnosis 
of thrombolysis 
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ACRONYMS 
 RV   -  RIGHT VENTRICLE 
 LV   -  LEFT VENTRICLE 
 LAD   -  LEFT ANTERIOR DESCENDING ARTERY 
 RCA  -  RIGHT CORONARY ARTERY 
 LCX   -  LEFT CIRCUMFLEX ARTERY 
 PTCA  -  PERCUTANEOUS TRANSLUMINAL  
    CORONARY  A NGIOPLASTY 
 EF   -  EJECTION FRACTION 
 TIMI   -  THROMBOLYSIS IN MYOCARDIAL  
    INFARCTION 
 EF   -  EJECTION FRACTION 
 RAO   -  RIGHT ANTERIOR OBLIQUE 
 LAO   -  LEFT ANTERIOR OBLIQUE 
 AP   -  ANTEROPOSTERIOR 
 
 
PROFORMA 
CORONARY ANGIOGRAPHICPROFILE IN 
FAILED THROMBOLYSIS 
 
NAME                   AGE                    SEX                 HGT  
                                                                                         
WGT 
DIAGNOSIS 
 
ADDRESS 
 
 
DEMOGRAPHIC AND OTHER BASELINE CHARACTERISTIC  
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P 
VALUE 
 NO                % NO                     %  
AGE    
FEMALES    
DIABETES MELLLITUS    
HYPERTENSION    
SMOKER    
HYPERCHOLESTRELEMIA    
 
TIME TO THROMBOLYSIS FROM ONSET OF SYMPTOMS 
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P 
VALUE 
 NO % NO %  
THROMBOLYSIS < 3HRS       
THROMBOLYSIS 3- 12 
HRS 
     
Thrombolysis >12-24 hrs      
MEAN TIME TO 
THROMBOLYSIS 
     
 
RESOLUTION OF CHEST PAIN 
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
NO % NO % 
RESOLUTION OF CHEST 
PAIN < 2 HRS 
     
RESOLUTION OF CHEST 
PAIN> 2 HRS 
     
MEAN TIME FOR  
RESOLUTION OF CHEST 
PAIN 
     
 
MYOCARDIAL SEGMENTS INVOLVED 
 
 
 
SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
NO % NO % 
ANTERIOR WALL 
MYOCARDIAL 
INFARCTION 
     
INFERIOR WALL 
MYOCARDIAL 
INFARCTION 
     
 
EJECTION FRACTION 
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
EF >55%    
54-45%    
44-35%    
<35%    
 
 
PATTERN OF CORONARY ARTERY INVOLVED 
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
LAD    
RCA    
LCX     
LEFT MAIN     
 
PERCENTAGE STENOSIS 
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
<50% STENOSIS    
50- 70% STENOSIS    
>70% STENOSIS    
 
LESION CHARACTERISTICS 
 SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
TYPE A    
TYPE B    
TYPE  C    
 
TIMI FLOW 
TIMI FLOW SUCCESSFUL 
THROMBOLYSIS 
FAILED 
THROMBOLYSIS 
P VALUE 
0    
1    
2    
3    
 
 
NAME AGE SEX AWMI IWMI
TIME TO 
LYSIS
CHEST 
PAIN 
RELIEF DM HT SMOKER ALCOHOL T.C TGL EF SVD DVD TVD <50 50-75 >75-95
TOTAL 
OCCLUSION
VENKATESAN 40 M Y N 1 1 N N N N 146 1O2 3 N N N N N N N
vijaya 42 F Y N 2 1 N N N N 122 90 2 N N N YL N N N
kannan 42 M Y N 1 1 N N Y N 126 94 2 Y N N N N YL N
KULASEKARAN  63 M N Y 1 1 N N Y Y 142 110 1 N Y N N N YL,YR N
SUNDARESAN 60 M N Y 2 2 N N N N 152 124 1 Y N N N YR N N
ABDULLAH       63 M N Y 1 1 Y N N N 142 110 1 N N N YX N N N
MOHAN 55 M N Y 2 1 N N N N 144 124 1 Y N N YL N Y N
PANNERSELVAM 59 M N Y 1 1 N N Y Y 124 96 2 Y N N YX YR N N
JAGANATHAN 40 M Y Y 1 1 Y N N N 136 122 2 N N N N N N N
PAZHAMALAI 63 M y N 1 1 N Y Y Y 148 102 2 N N N YX N N N
CHANDRASEKAR 38 M N Y 2 1 N N Y Y 124 96 2 N N N YR N N N
CHANDRU           48 M Y N 2 1 N N Y N 138 112 3 N N N N N N N
CHINNADURAI  43 M Y N 2 2 N N Y N 164 126 2 N N N YL N N N
GNANAPRAKASAM 70 M N Y 2 1 Y Y Y N 138 102 1 N N N YR N N N
PONNUSWAMY   65 M N Y 2 1 N N N N 160 134 1 Y N N N N YR N
MOORTHY         45 M Y N 1 1 N Y Y N 136 120 2 N N N N N N N
HAJAMOIDEEN 60 M N Y 1 1 N N Y Y 124 95 1 N N N YR N N N
SUBRAMANI 42 M Y N 3 1 N N Y Y 144 90 1 N N N N N N N
SHANKAR 37 M N Y 1 1 N N Y Y 138 110 2 N N N N N N N
PRABHU 45 M N Y 2 1 N N Y N 148 112 1 N N N N N N N
HABIB MOHAMMED 50 M Y N 1 1 N N Y Y 168 118 2 N N N YL N N N
RAJA 44 M Y N 2 1 N N N N 178 134 2 N N N N N N N
JOHNSON 44 M Y N 1 1 N N Y N 146 112 3 N N N YL N N N
JAYACHANDRAN 32 M N Y 1 1 N N Y N 188 140 3 Y N N N YL N N
VARDHARAJAN 32 M Y N 2 1 N N Y N 136 102 3 N N N N N N N
LOGANATHAN  50 M Y N 2 1 Y N Y N 122 84 2 N N N YL N N N
PRABHAKARAN 34 M Y N 2 1 N N Y N 138 94 2 N N N N N N N
GOPAL    43 M Y N 1 1 N N Y Y 138 104 2 N N N YL N N N
HAROON SIDDI 66 M N Y 1 1 Y Y Y N 164 104 1 N N N N N N N
VIYAPURI 51 M N Y 1 1 N N Y N 164 130 1 N N N YR N N N
BHAKTAVACHALAM 60 M Y N 1 2 N N N N 144 112 2 N N N YR N N N
MASTER CHART 
NAME 
VENKATESAN
vijaya
kannan
KULASEKARAN  
SUNDARESAN 
ABDULLAH       
MOHAN
PANNERSELVAM
JAGANATHAN 
PAZHAMALAI
CHANDRASEKAR
CHANDRU           
CHINNADURAI  
GNANAPRAKASAM 
PONNUSWAMY   
MOORTHY         
HAJAMOIDEEN 
SUBRAMANI 
SHANKAR
PRABHU
HABIB MOHAMMED 
RAJA
JOHNSON
JAYACHANDRAN 
VARDHARAJAN 
LOGANATHAN  
PRABHAKARAN 
GOPAL    
HAROON SIDDI 
VIYAPURI
BHAKTAVACHALAM
LAD
 
TYPEA
LAD 
TYPEB
LAD 
TYPEC
RCA 
TYPEA        
RCA 
TYPEB
RCA 
TYPEC
LCX 
TYPE 
A      
LCX 
TYPEB
LCX 
TYPE C
LEFT
 MAIN TIMI FLOW TL TR TX DOMINANCE
NO 
REFLOW
TIMI 
IN 
IRA
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N TL2 2 3 3 1 Y 2
Y N N N N N N N N N TL2 2 3 3 1 N 2
N Y N N Y N N N N N TL2,TR2 2 2 3 3 N 2
N N N N Y N N N N N TR2 3 2 3 1 N 2
N N N N N N N N N N 3 3 3 3 1 N 3
N Y N N N N N N N N TL2 2 3 3 1 N 2
N N N N Y N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N TX2 3 3 2 2 Y 2
N N N N N N N N N N 3 3 3 3 1 N 3
N Y N N N N N N N N 3 3 3 3 1 N 3
N N N N Y N N N N N 3 3 3 3 1 N 3
N N N Y N N N N N N TR2 3 2 3 1 N 2
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 Y 3
N N N N N N N N N N TL2 2 3 3 2 Y 2
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N TL2 2 3 3 1 Y 2
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N Y N N N TX2,TR2 3 2 2 1 N 2
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N TL2 2 3 3 1 Y 2
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N 3 3 3 3 1 N 3
N N N N N N N N N N TL2 2 3 3 1 Y 2
NAME AGE SEX AWMI IWMI
TIME 
TO 
LYSIS
CHEST 
PAIN 
RELIEF DM HT SMOKER ALCOHOL T.C TGL EF SVD DVD TVD <50 50-75 >75-95
SUBRAMANI 40 M Y N 2 1 N Y N N 194 156 4 N N N N N N
SIVASHANMUGAM 52 M Y N 3 2 N N N N 206 182 2 Y N N N YL N
KRISHNAN 68 M Y N 1 2 Y Y N N 144 140 3 N N Y N YR YL YX
GOVINDARAJ  60 M N Y 1 2 N N Y N 210 162 2 Y N N N YR N
SHANKAR   52 M Y N 2 2 N N Y Y 184 152 2 N Y N Y YL YX N
RAJENDRAN 60 M Y N 1 1 N Y Y N 176 130 3 N Y N N YR YL
GANESAN  43 M Y N 2 2 Y Y N N 201 164 3 Y N N N N Y
JAWARILAL      61 M Y N 2 1 N N N N 179 112 2 Y N N N YR N
ANANDAN       52 M N Y 2 2 Y Y Y N 129 79 3 N N Y N YX YR YL
PERMAL 63 M y N 2 2 N N Y Y 224 144 3 Y N N N N YL
SUBRAMANI    50 M Y N 2 2 Y N N N 176 154 2 Y N N N N YL
RAJENDRAN  52 M Y N 2 2 N N N N 102 91 3 N Y N N N YL YR
SHANKAR   52 M Y N 2 1 Y Y N N 168 144 2 N N N N N N
KRISHNAN  68 M Y N 2 2 Y Y Y N 186 164 3 N N Y N YR YL YX
BENJAMIN 61 M Y N 2 1 N N N N 216 178 3 Y N N N N YL
KUPPUSWAMY 54 M Y N 2 1 N N Y N 142 99 2 Y N N N N YL
SURESHKUMAR 48 M N Y 2 2 Y N Y N 173 184 2 Y N N N N YR
KARUPIYAN  45 M N Y 3 2 N N Y N 142 164 2 Y N N N YX N
JAYARAMAN 50 M Y N 2 1 N N Y Y 141 125 2 N N N N N N
SIVAKUMAR   28 M Y N 2 2 N N Y N 136 172 3 Y N N N N YL
SUBBIYA           54 N Y 2 2 Y N N N 196 174 1 Y N N N YL N
BABU 38 M Y N 3 2 N N Y Y 189 130 3 Y N N N YL N
SUBRAI MAN 61 M Y N 3 2 Y N Y N 197 154 3 N Y N YL YR YL
MANIKANDAN 50 M Y N 2 2 Y N Y N 180 162 3 N N Y N YX YL YR
RAJASEKAR 51 M Y N 2 2 Y Y Y N 174 144 3 N Y N N YL YX N
DHANAPAL 60 M Y N 2 2 Y Y Y Y 184 148 3 N N Y N YR YX YL
KARNAKARAN 46 M Y N 2 2 Y Y Y N 210 160 2 Y N N N YL N
DAMODHARAN      60 M Y N 2 1 Y Y Y N 216 142 3 N Y N N YL YR
MASTER CHART
NAME 
SUBRAMANI
SIVASHANMUGAM
KRISHNAN
GOVINDARAJ  
SHANKAR   
RAJENDRAN
GANESAN  
JAWARILAL      
ANANDAN       
PERMAL
SUBRAMANI    
RAJENDRAN  
SHANKAR   
KRISHNAN  
BENJAMIN 
KUPPUSWAMY
SURESHKUMAR
KARUPIYAN  
JAYARAMAN 
SIVAKUMAR   
SUBBIYA           
BABU
SUBRAI MAN
MANIKANDAN
RAJASEKAR 
DHANAPAL 
KARNAKARAN 
DAMODHARAN      
TOTAL 
OCCLUSION
LAD 
TYPEA
LAD 
TYPEB
LAD 
TYPEC
RCA 
TYPEA        RCA 
TYPEB
RCA 
TYPEC
LCX 
TYPE A              
LCX 
TYPEB
LCX 
TYPE C
LEFT
 MAIN TIMI FLOW TL TR TX DOMINANCE ANGINA
1TIMI 
IN IRA
N N N N N N N N N N N 3 3 3 3 1 N 3
N N YL N N N N N N N N TL1 1 3 3 1 Y 1
N N Y N Y N N Y N N N TL2 TX2 TR2 2 2 2 1 Y 2
N N N N N N Y N N N N TR2 3 2 3 1 N 2
N N Y N N N N N Y N N TL2 TX2                       12 3 2 1 Y 2
N N Y N N N Y N N N N TL1 TR2 1 2 3 1 N 2
N Y N N N N N N N N N TL1 1 3 3 1 N 3
N N Y N N N N N N N N TL2 2 3 3 1 N 2
YL N N Y N Y N N Y N N TL0,TR2,TX2              10 2 2 1 N 0
N N Y N N N N N N N N TL2 2 3 3 1 Y 2
N N Y N N N N N N N N TL2 2 3 3 1 N 2
N N Y N N Y N N N N N TL2  TR2 2 2 3 1 N 2
N N N N N N N N N N N 3 3 3 3 1 N 3
N N Y N Y N N Y N N N TL2 TR2 TX2              12 2 2 1 Y 2
N N Y N N N N N N N N TL2 2 3 3 1 N 2
N Y N N N N N N N N N TL2 2 3 3 1 N 2
N N N N N Y N N N N N TR1 3 1 3 1 N 1
N N N N N N N N Y N N TL2 2 3 3 3 N 2
N N N N N N N N N N N TL2 TR2 2 2 3 1 Y 2
YL N Y N N N N N N N N TL0                              10 3 3 1 Y 0
N N Y N N N N N N N N TL2 2 3 3 1 Y 2
N Y N N N N N N N N N TL2 2 3 3 1 N 2
YL N N Y N N Y N N N N TL0 TR1 0 1 3 2 N 0
N N Y N Y N N N N Y N TL2 ,TR2,TX0          12 2 0 1 N 2
N Y N N N N N Y N N N TL2 TX2 2 3 2 1 N 2
N N N Y N N Y N Y N N TL0 TX2 TR2 0 2 2 1 N 0
N N YL N N N N N N N N TL2 2 3 3 1 N 2
N N YL N N YR N N N N N TL2  TR2 2 2 3 1 N 2
CONSENT FORM 
 
 I hereby consent to participate in the above study  
       Signature of the Participant 
Information to Participants 
 
Title : ANGIOGRAPHIC PROFILE IN PATIENTS WITH FAILED 
THROMBOLYSIS 
Principal Investigator: Dr.M.SARAVANAN 
Co-Investigator (if any): 
Name of Participant: 
Site:   RGGGH& MMC, Chennai 
 You are invited to take part in this research/ study/procedures/tests. The 
information in this document is meant to help you decide whether or not to take 
part. Please feel free to ask if you have any queries or concerns. 
What is the purpose of research? 
IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION, 
WHAT IS THE RATE OF THROMBOLYSIS FAILURE, 
ANGIOGRAPHIC LESION CHARACTERISTIC IN PATIENTS 
WITH FAILED THROMBOLYSIS. we have obtained permission 
from the institutional ethics committee.  
The study design 
 It is a Prospective study. 
Study Procedures 
• The study involves evaluation at the bedside clinically, 
electrocardiographically, and angiographically in patients with failed 
and successful thrombolysis. 
 
Confidentiality of the information obtained from you 
 You have the right to confidentiality regarding the privacy of your 
medical information (personal details, results of physical examinations, 
investigations, and your medical history). By signing this document, you will 
be allowing the research team investigators, other study personnel, sponsors, 
Institutional Ethics Committee and any person or agency required by law like 
the Drug Controller General of India to view your data, if required. 
 The information from this study, if published in scientific journals or 
presented at scientific meetings, will not reveal your identity. 
How will your decision to not participate in the study affect you? 
 Your decision not to participate in this research study will not affect 
your medical care or your relationship with the investigator or the institution. 
You will be taken care of and you will not lose any benefits to which you are 
entitled.  
Can you decide to stop participating in the study once you start? 
 The participation in this research is purely voluntary and you have the 
right to withdraw from this study at any time during the course of the study 
without giving any reasons. However, it is advisable that you talk to the 
research team prior to stopping the treatment/discontinuing of procedures etc. 
 
Signature of Investigator                                    Signature of Participant   
Date                                                                     Date 
 
PATIENT CONSENT FORM 
STUDY TITLE:  “Coronary angiographic profile in patients with failed thrombolysis” 
Patient may check (9) these boxes. 
PARTICIPANT NAME:                                          DATE:  
 AGE:               SEX:                                    I.P.NO. : 
The details of the study have been provided to me in writing and explained 
to me in my own language. 
I confirm that I have understood the purpose of the above study. I have the 
opportunity to ask the question and all my questions and doubts have been 
answered to my complete satisfaction. 
I understand that my participation in the study is voluntary and that I am free 
to withdraw at any time without giving any reason, without my legal rights 
being affected. 
I understand that investigator, the institution, regulatory authorities and the 
ethical committee will not need my permission to look at my health records 
both in respect to the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study. I understand 
that my identity will not be revealed in any information released to third 
parties or published, unless as required under the law.  
I agree not to restrict the use of any data or results that arise from this study.  
 I hereby consent to undergo complete physical examination, and diagnostic 
tests including hematological, biochemical, radiological and urine 
examinations 
I have been given an information sheet giving details of the study 

 
